Article Topic
Counterfeit Medicine News for the Week of November 9, 2020
In PSM’s round-up this week: An analysis of New Mexico’s draft drug importation plan, reports on COVID-19 fraud, and this week in counterfeit medicine news.
[...]An Analysis Of New Mexico’s Draft Canadian Drug Importation Plan
The state of New Mexico released a draft of its Canadian drug importation plan. PSM analyzed the plan, paying particular attention to concerns pharmacists might have about how drug importation might affect their patients and business…
[...]Counterfeit Medicine News for the Week of November 2, 2020
In PSM’s round-up this week: FDA and FTC warnings over fake COVID-19 treatments and fraud, as well as fake medicine news in seven U.S. states, Canada and Cambodia.
[...]Jake Beddoe Sheltered from COVID-19, Only to Die from Fake Xanax
Seeking a good night’s sleep, 25-year-old Jake Beddoe, a young travel consultant with an adventurous heart and a tremendous sense of humor, took part of what he thought was a Xanax pill on May 27, 2020. The pill was counterfeit, and Jake died of fentanyl poisoning.
[...]Counterfeit Medicine News for the Week of October 26, 2020
In PSM’s round-up this week: news about state drug importation, COVID-19 fraud, fake hand sanitizer stations, and more counterfeit medicine news.
[...]Deadly Counterfeit Pills Found in All 50 U.S. States; Deaths Now Reported in 42 of Them (Archived)
With the recent report that police in Maui, Hawaii seized 400 counterfeit oxycodone pills made with fentanyl on October 2, 2020, the United States has reached a sobering milestone: public sources have reported about fake pills made with fentanyl in all 50 states.
[...]Counterfeit Medicine News for the Week of October 19, 2020
In PSM’s round-up this week: news about state drug importation, COVID-19 fraud, deadly workout supplements and counterfeit pills made with fentanyl.
[...]“Reducing costs requires more than all of this non–value-added activity,” Expert Says
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
[...]Counterfeit Medicine: Crime and Policy, October 20, 2020
A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
[...]Counterfeit Medicine News for the Week of October 12, 2020
In PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.
[...]